Data Integrity

Securing the integrity of your electronic data and records is critical for safeguarding patient safety

Data Integrity Services

Signal management icon

Data Integrity Risk Assessments

We take a consistent, standardized approach when performing data integrity risk assessments to fully encompass the requirements documented by the US FDA, EMA, MHRA,...

Read More

Data Integrity Risk Assessments

We take a consistent, standardized approach when performing data integrity risk assessments to fully encompass the requirements documented by the US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA.

Read Less
Safety systems icon

Policies & Procedures Framework

We will ensure that data integrity is “built-in” from the start. Our data integrity consultants can have a QMS framework ready in a few weeks.

Policies & Procedures Framework

We will ensure that data integrity is “built-in” from the start. Our data integrity consultants can have a QMS framework ready in a few weeks.

Read Less
Global literature review icon

Essential Training for Your Organization

Our catalog of Data Integrity training courses can be provided ‘as is’ or tailored to include examples from your daily operations.

Essential Training for Your Organization

Our catalog of Data Integrity training courses can be provided ‘as is’ or tailored to include examples from your daily operations.

Read Less
Computer System Validation icon

Data Governance Programs

We guide you through the steps of implementing a Data Integrity Program to monitor data integrity practices and ensure they continue to mature. 

Data Governance Programs

We guide you through the steps of implementing a Data Integrity Program to monitor data integrity practices and ensure they continue to mature. 

Read Less
Submissions icon

Standard Compliant Documentation, Tailored for You

We tailor our standard suite of documents, built from US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA data integrity guidelines, to fit your...

Read More

Standard Compliant Documentation, Tailored for You

We tailor our standard suite of documents, built from US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA data integrity guidelines, to fit your organization. 

Read Less
Compliance

ALCOA Principles Applied

We follow a consistent, standardized approach when performing data integrity risk assessments to fully encompass ALCOA principles and requirements documented by the US FDA,...

Read More

ALCOA Principles Applied

We follow a consistent, standardized approach when performing data integrity risk assessments to fully encompass ALCOA principles and requirements documented by the US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA.

Read Less

Data Integrity Risk Assessments

Everyone has heard the acronym "ALCOA", but our experts have experience assessing real-life situations vs. the principles of ALCOA to identify data integrity risks.

The purpose of a data integrity risk assessment is to provide you with the information you need to mitigate data integrity risks before your organization has a serious data integrity issue.

ProPharma’s data integrity consultants follow a consistent, standardized approach when performing data integrity risk assessments to fully encompass the requirements documented by the US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA.

Business worker with virtual attendees in conference room
Hands gesturing around a table with various charts and graphs

Here are the steps we take:

  • Meet to discuss your industry, products, and markets to determine the appropriate regulatory guidelines and any specific areas of concern, e.g., from CAPAs or past audits.
  • Tailor our standard assessment checklists to place the emphasis on the areas of highest risk.
  • Conduct the data integrity risk assessment – policies and procedures first, then specific systems and processes. The assessments include demonstrations of system functionality, review of policies and procedures, interviews with subject matter experts, and review of validation documentation.
  • Provide a Data Integrity Risk Assessment report identifying the areas of data integrity risk. Each risk is categorized as ‘critical’, ‘major’, or ‘minor’ to aid in prioritization of remediation activities.
  • Provide a Report of Recommended Actions for closure of each data integrity risk.
  • Facilitate follow-up meetings to ensure that the risks and recommendations are understood.

Data Integrity Framework of Policies & Procedures

A robust suite of Policies, Procedures, Work Instructions, and Templates provides the framework to ensure that data integrity is “built-in” from the start. ProPharma’s experienced data integrity consultants can have a QMS framework ready in a few weeks.

Here are the steps we take:

  • Meet to discuss what makes your organization unique, e.g.,
    • Industry-specific regulations, e.g., AOPO, CAP, COLA
    • Organization structure, roles, and responsibilities
    • Computer systems and tools already in use
  • Tailor ProPharma’s standard suite of documents, built from US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA data integrity guidelines, to fit your organization.
  • Solicit feedback on the preliminary suite of documents and make adaptations before finalizing the Policies, Procedures, Work Instructions, and Templates.
  • Develop a Quality Manual to summarize the Policy and Procedure framework and provide an overview for employees, auditors, and inspectors.
Hand holding pen between fingers typing on laptop and using tablet device
Man using mobile phone tablet and laptop next to stethoscope and spiral notebook

Data Integrity Training

Delivering the right level of training at the right time is essential for embedding the principles of data integrity into company culture.

ProPharma has a catalog of Data Integrity training courses that can be provided ‘as is’ or tailored to include examples from your daily operations.

  • Short training courses on Data Integrity Principles, suitable for Data Integrity program implementation and annual refresher training
  • Longer training courses on advanced Data Integrity topics such as:
    • ALCOA in Practice
    • Data Integrity Roles & Responsibilities
    • Data Governance Models
    • Digital Signatures
    • Computer System Validation

Data Governance Programs

A Data Governance program is more than simply determining who ‘owns’ the data.  It’s a program to monitor data integrity practices in real-time and ensure that they continue to mature.

ProPharma’s data integrity consultants will guide you through the steps of implementing a Data Integrity Program that includes:

  • A structured program with defined roles and responsibilities for both leaders and subject matter experts
  • Processes for real-time monitoring of data integrity health through ongoing review of internal audit findings, metrics, and incident reports
  • Processes for prioritizing and initiating course corrections to ensure that issues are not repeated, and data integrity health metrics continue to improve
  • Standard process for building a roadmap to improve the organization’s Data Integrity program through strategic investments and targeted process improvements
Medical professionals business professionals working at a conference table
Validation Center Logo

Data Integrity Training & Resources

Access essential training and resources for computer system validation, compliance, and data integrity at Validation Center, ProPharma knowledge center and resource.

Attend free webinars, enroll in online and in-person classes in the US and Europe, and download valuable templates and standard operating procedures. Validation Center offers everything you need for CSV and software quality assurance.

Meet our Data Integrity Experts

  • Deb Bartel Bio Photo

    Deb Bartel

    Vice President of Quality Assurance

  • Rodrigo Perez Bio Photo

    Rodrigo Perez

    Associate Director, Computer System Validation & Data Integrity

News & Insights

Is Your Clinical Trial at Risk: When to Consider a Rescue Strategy

August 6, 2026

Is Your Clinical Trial at Risk: When to Consider a Rescue Strategy

Identify the warning signs of a clinical trial at risk and learn when to implement a structured rescue strategy to ensure study success and data integrity.

Top 7 QMSR Readiness Gaps Medical Device Manufacturers Should Assess Before an FDA Inspection

August 5, 2026

Top 7 QMSR Readiness Gaps Medical Device Manufacturers Should Assess Before an F...

FDA's QMSR is now in effect. Learn the seven most common quality system gaps medical device manufacturers should assess to prepare for FDA inspections and achieve QMSR compliance.

Efficiency and Compliance: Mastering Legal Case Processing in Pharmacovigilance

August 3, 2026

Efficiency and Compliance: Mastering Legal Case Processing in Pharmacovigilance

Explore strategies for efficient legal case processing in pharmacovigilance, ensuring compliance and enhancing patient safety amidst rising litigation challenges.

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Achieving Continuous Audit Readiness Across a Global Medical Information Program - ProPharma

August 3, 2026

Achieving Continuous Audit Readiness Across a Global Medical Information Program

Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...

Case Study Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation - ProPharma

July 23, 2026

Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation

As artificial intelligence becomes increasingly embedded across life sciences, organizations face a growing challenge: ensuring quality and compliance frameworks evolve alongside rapidly advancing...

Case Study Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A Regulatory and Pharmacovigilance-Led Solution - ProPharma

July 15, 2026

Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A...

Product shortages involving essential medicines can create significant clinical and regulatory challenges, particularly when vulnerable patient populations depend on uninterrupted access to...

From Feasibility to First Patient In: How to Streamline Study Start-Up  

September 30, 2026

From Feasibility to First Patient In: How to Streamline Study Start-Up  

Clinical trial delays often begin long before study conduct, with critical decisions made during feasibility and study start-up shaping the success of the entire trial. Join this webinar to discover...

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

June 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

News & Insights

Is Your Clinical Trial at Risk: When to Consider a Rescue Strategy

August 6, 2026

Is Your Clinical Trial at Risk: When to Consider a Rescue Strategy

Identify the warning signs of a clinical trial at risk and learn when to implement a structured rescue strategy to ensure study success and data integrity.

Top 7 QMSR Readiness Gaps Medical Device Manufacturers Should Assess Before an FDA Inspection

August 5, 2026

Top 7 QMSR Readiness Gaps Medical Device Manufacturers Should Assess Before an F...

FDA's QMSR is now in effect. Learn the seven most common quality system gaps medical device manufacturers should assess to prepare for FDA inspections and achieve QMSR compliance.

Efficiency and Compliance: Mastering Legal Case Processing in Pharmacovigilance

August 3, 2026

Efficiency and Compliance: Mastering Legal Case Processing in Pharmacovigilance

Explore strategies for efficient legal case processing in pharmacovigilance, ensuring compliance and enhancing patient safety amidst rising litigation challenges.

Previous Post Arrow Next Post Arrow
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Achieving Continuous Audit Readiness Across a Global Medical Information Program - ProPharma

August 3, 2026

Achieving Continuous Audit Readiness Across a Global Medical Information Program

Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...

Case Study Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation - ProPharma

July 23, 2026

Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation

As artificial intelligence becomes increasingly embedded across life sciences, organizations face a growing challenge: ensuring quality and compliance frameworks evolve alongside rapidly advancing...

Case Study Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A Regulatory and Pharmacovigilance-Led Solution - ProPharma

July 15, 2026

Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A...

Product shortages involving essential medicines can create significant clinical and regulatory challenges, particularly when vulnerable patient populations depend on uninterrupted access to...

Previous Resource Arrow Next Resource Arrow
From Feasibility to First Patient In: How to Streamline Study Start-Up  

September 30, 2026

From Feasibility to First Patient In: How to Streamline Study Start-Up  

Clinical trial delays often begin long before study conduct, with critical decisions made during feasibility and study start-up shaping the success of the entire trial. Join this webinar to discover...

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

June 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Previous Webinar Arrow Next Webinar Arrow

Customized Strategy. Globally Scaled Solutions

ProPharma helps clients mitigate data integrity risks and ensure compliance with FDA, EMA, MHRA, and other agency standards.